The use of the decision aid improved informed decision-making regarding prenataltesting.
2
Genetic diagnosis can also provide a possibility for prenataltesting.
3
It is an essential quality control component of noninvasive prenataltesting (NIPT) results.
4
Healthcare professionals should take these differences into consideration when counseling pregnant women on prenataltesting.
5
This technology is potentially valuable for using circulating plasma nucleic acids for prenataltesting and research.
1
Background: Massively parallel sequencing has recently been used in noninvasive prenataldiagnosis.
2
The decisions and practices in prenataldiagnosis should be debated throughout society.
3
The introduction of fetal echocardiography has made prenataldiagnosis of CHD possible.
4
This enabled us to provide definitive prenataldiagnosis at 10 weeks' gestation.
5
There is no specific ultrasound prenataldiagnosis and no identified genetic locus.
1
Circulating fetal nucleated cells (CFNCs) have shown potential in noninvasive prenataldiagnostics.
2
Genetic sequencing is currently used in limited capacity to study patients' cancer tumors or in prenataldiagnostics.
3
Examination of LOH is useful for prenataldiagnostics especially when time is lacking due to patient's pregnancy or in case of mutation screening failure.
4
Analyses in Denmark were restricted to the period before prenataldiagnostics became available (2004) and pregnancy terminations of fetuses with birth defects became more common.
Uso de prenatal screening en inglés
1
The intervention group additionally received an information booklet about prenatalscreening and diagnosis.
2
Data were collected on the prenatalscreening method, diagnosis, and delivery.
3
Main outcome measures: Women's knowledge score of prenatalscreening.
4
Our data showed that the prenatalscreening rate of CHD appears satisfactory in Southern France.
5
These results justify efforts to improve prenatalscreening programs.
6
This study did not find any benefit in terms of mortality from prenatalscreening for CHD.
7
Genetic evaluation consisted of noninvasive prenatalscreening (NIPS) or amniocentesis.
8
We evaluated performance characteristics of a laboratory-developed, non-invasive prenatalscreening (NIPS) assay for fetal aneuploidies.
9
Objective: This study evaluates pregnant women's and healthcare professionals' preferences regarding specific prenatalscreening and diagnostic test characteristics.
10
The majority of women receiving an abnormal result on routine prenatalscreening subsequently give birth to unaffected children.
11
Proponents of prenatalscreening and the new abortion legislation say it's all about giving women information, and choice.
12
Noninvasive prenatalscreening (NIPS) is revolutionizing prenatalscreening as a result of its increased sensitivity, specificity.
13
The correlation between education, knowledge score, experiential knowledge of congenital disabilities, and the likelihood of accepting prenatalscreening.
14
Objective: Yearly, 450 000 pregnant Canadians are eligible for voluntary prenatalscreening for trisomy 21.
15
Recently, practices have begun integrating cell-free DNA-based noninvasive prenatalscreening as a screening option for a variety of genetic conditions.
16
Nevertheless, our results, suggest that NT is not a very effective or efficient tool for the prenatalscreening of CHD.